Search for: "PFIZER INC. et al v. mylan
inc. et al"
Results 1 - 10 of 10
Sorted by Relevance | Sort by
Date
15 Jun, 2007 8:11 am
... and rehearing en banc was denied. The technology at issue, amlodipine besylate tablets, is commercially sold in the United States by Pfizer
under the trademark Norvasc®. Amlodipine is a member of a class of compounds referred to as dihydropyridines. Active drug molecules, such as ... in anticipation of the KSR ruling (See,
e.g., Dystar Textilfarben GMBH & Co Deutschland KG v. C.H. Patrick, Co., et al., Alza Corporation v. Mylan Laboratories, Inc., et al., and Ormco Corporation, et al. v. Align ...
17 Nov 10:24 am
... RE: PLASMA-DERIVATIVE PROTEIN THERAPIES ANTITRUST LITIGATION Motion of plaintiff Hospital Damas, Inc., for centralization of the following actions in the United States
District Court for the Northern District of Illinois: ... District of Pennsylvania: District of Massachusetts Michael Alan Caltieri, etc. v. Pfizer Inc., et al., C.A. No. 1:09-11480 Eastern District of Pennsylvania ... . 8:09-1098 District of Delaware Eurand, Inc., et al. v. Mylan Pharmaceuticals, Inc., et al., C.A. No. 1:08-889 Eurand, ...
27 Jun, 2008 10:04 am
... amp; Biotech Pharma & Biotech - General 'Inventing around' patents: Astra v Mylan and implications for the 'access' debate:
(Spicy IP), Access to Medicine Index ... process and improper attempt to relitigate validity: Pfizer Canada Inc et al v Novopharm Limited
et al:
(Pharmacapsules@Gowlings), Yasmin (Drospirenone) - US ... reconsidering baseless 'making available' theory in file-sharing case Capitol Records v Jammie Thomas; amicus briefs
from, MPAA, PFF: (Electronic Frontier Foundation), (Electronic ...
11 Jun, 2007 3:43 am
... 2007. All opinions are precedential unless otherwise indicated. NMT Medical, Inc., et
al. v. Cardia, Inc. (06/06/2007, non-precedential): appeal of grant of ... claim 12 is
vacated; request for summary judgment for infringement denied Pfizer, Inc. v. Mylan
Laboratories, Inc., et al. (order) (06/08/2007, non-precedential): ... Pfizer's petition for rehearing en banc in that case and the
mandate issued; Mylan's motion for summary reversal is granted, and the district court's judgment and amended judgment ...
20 May 5:18 am
... Gamble's Actonel patent validity; nonobviousness of positional isomer: Procter & Gamble v Teva (Patent Docs) (Patently-O) (SmartBrief) (SmartBrief) (GenericsWeb) Alimta
(Pemetrexed) - ... Ortho-McNeil Pharmaceutical et al v Lupin Pharmaceutical et al (FDA Law Blog) (FDA Law Blog) Lyrica (Pregabalin) - US: Pfizer, Warner-Lambert
and CP Pharmaceuticals file patent infringement suit against Mylan and Alphapharm in attempt to block generic Lyrica (GenericsWeb) Mucinex
(Guaifenesin, Pseudoephedrine) ...
28 Mar, 2008 6:00 am
... briefs filed and Mylan enters the fray: (FDA Law Blog), Tarceva (Erlotinib) - Delhi Patent Office hears arguments on whether
Roche/Pfizer enjoy the right to ... and District of Columbia file lawsuit alleging Abbott Laboratories, Fournier Industrie et Sante SAS, and Laboratoire Fournier SA conspired to delay a generic version ... Federal Court considers the meaning of
'relevant to work in the relevant art': Ajinomoto Co Inc v Nutrasweet Australia Pty Ltd: (Mallesons Stephen Jaques), Society of Authors' ...
9 Sep 7:14 am
... ' includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation ... challenge (Patent Docs) Cipro (Ciprofloxacin) - US: California court rules that Bayer AG et al did not violate state antitrust law in
Cipro reverse payment case ... (Efavirenz) - US: Bristol-Myers Squibb files patent infringement suit against Mylan, Matrix in response to Para
IV challenge (Patent Docs) Viread (Tenofovir) - India: ...
4 Apr, 2008 1:00 am
... v Yahoo; US case Storus Corp v Aroa Marketing, Inc et al: (IMPACT), World's strongest and most valuable brands revealed in new issue ... (Philip Brooks), (IPBiz), (IP Law360),
Lipitor (Atorvastatin) / Caduet (Atorvastatin/Amlodipine) - Pfizer sues Ranbaxy in US federal court alleging infringement of two of its Lipitor
process patents ... (Topiramate) - US CAFC upholds Ortho-McNeil's Topamax patent in its dispute with Mylan Laboratories: (IP Law360), (Hal
Wegner), (Patent Prospector), (Orange Book Blog), ...
11 Jul, 2008 4:30 am
... IP Factor), Sutent (Sunitinib) / Tarceva (Erlotinib) - India: Assistant Controller of Patents rules that Pfizer has a right to be heard in
compulsory licensing application filed by Natco to export generic ... - Insurance contract copying lawsuit proceeds: MDM Group Associates, Inc v Emerald Isle Realty,
Inc: (43(B)log), Mercedes-Benz USA - WordLogic ... Motion - Stay pending patent re-examination granted in Visto Corp v RIM, et al: (EDTexweblog.com), RIAA - North Carolina judge decides to take a
fresh ...
8 May 8:00 am
... jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a
laundry list ... Doryx (Doxycycline) - US: Warner Chilcott files new lawsuit for infringement of Doryx patent against Mylan (SmartBrief)
(GenericsWeb) Famvir (Famciclovir) - US: Novartis denied jury trial in Famvir suit against Roxane Labs (Patent Docs) Lyrica (Pregabalin) - US: Pfizer files patent infringement suits ...
Search on: Blawgs.FM | BlawgSearch Google
Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!